An experimental Parkinson’s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.
Related Posts
Jean Paul Gaultier Owner Puig Brands Posts Higher Revenue Boosted by Fragrances
The owner of brands including Jean Paul Gaultier, Carolina Herrera and Nina Ricci increased sales by 11% in the third quarter, beating analysts’ forecasts.
Southwest Raises Revenue Forecast, Plans Share Buyback in Activist Battle
The airline’s first flights with assigned seats are scheduled to take off in 2026, among a series of radical changes Southwest is making to its […]
Dollar Tree CFO Departs; Raises Full-Year Sales View
Dollar Tree is parting ways with its top finance executive a month after its CEO stepped down. The discount retailer has also raised its full-year […]